A Study on the Control of Chronic Obstructive Pulmonary Disease (COPD) in Patients Taking the Combination of Tiotropium and Olodaterol Using the Respimat® Inhaler

NCT03663569 · clinicaltrials.gov ↗

COMPLETED

Status

4819

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: Spiolto® Respimat®

Sponsor

Boehringer Ingelheim